Does Dr. STEPHANIE JACKSON CULLISON have financial conflicts of interest?

Dr. STEPHANIE JACKSON CULLISON (MD) has received a total of $779 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $779 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. STEPHANIE JACKSON CULLISON?

According to CMS Open Payments data, Dr. STEPHANIE JACKSON CULLISON received funding from ABBVIE ($651), KERECIS LIMITED ($44), and REGENERON HEALTHCARE SOLUTIONS ($38).

Does Dr. STEPHANIE JACKSON CULLISON receive research grants or speaking fees?

Dr. STEPHANIE JACKSON CULLISON has received $779 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. STEPHANIE JACKSON CULLISON

MDReal-Time Hydrated

Specialty: Dermatology, MOHS-Micrographic Surgery

Practice Location: WILMINGTON, DE 19810

NPI Number: 1457705956

LIFETIME INDUSTRY VALUE

$779

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. JACKSON CULLISON is a verified Dermatology, MOHS-Micrographic Surgery practitioner based in WILMINGTON, DE.

Between 2021 and 2025, Dr. JACKSON CULLISON had an overall industry promotional and research financial footprint of $779 as recorded in the federal CMS Open Payments database.

$779 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. JACKSON CULLISON's primary funding source is ABBVIE, which accounts for $651 (representing 83.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$651

83.6%

KERECIS LIMITED

Rank 2

$44

5.7%

REGENERON HEALTHCARE SOLUTIONS

Rank 3

$38

4.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.